2023
DOI: 10.3390/jpm13010159
|View full text |Cite
|
Sign up to set email alerts
|

Sugammadex in Emergency Situations

Abstract: Sugammadex may be required or used in multiple emergency situations. Moderate and high doses of this compound can be used inside and outside the operating room setting. In this communication, recent developments in the use of sugammadex for the immediate reversal of rocuronium-induced neuromuscular blockade were assessed. In emergency surgery and other clinical situations necessitating rapid sequence intubation, the tendency to use rocuronium followed by sugammadex instead of succinylcholine has been increasin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 47 publications
0
1
0
Order By: Relevance
“…There is a lack of evidence in the current ICU guidelines [32] relating to monitoring neuromuscular blockade. In the postoperative setting, a residual neuromuscular blockade (TOF < 0.9) is still related to a high incidence of unfavorable outcomes such that quantitative monitoring is considered necessary in the intraoperative management of neuromuscular blockade [75], as recommended by the latest French guidelines [76] on muscle relaxants in 2020 and by new European Society of Anesthesia and Intensive Care and American Society of Anesthesiologists guidelines [75,77]. In accordance with these guidelines, the Italian intersociety consensus on perioperative anesthesia care in thoracic surgery recommends strict neuromuscular monitoring for correct administration of both NMBAs and reversal agents [78].…”
Section: Monitoring Of Neuromuscular Blockade and Adequacy Of Sedationmentioning
confidence: 99%
“…There is a lack of evidence in the current ICU guidelines [32] relating to monitoring neuromuscular blockade. In the postoperative setting, a residual neuromuscular blockade (TOF < 0.9) is still related to a high incidence of unfavorable outcomes such that quantitative monitoring is considered necessary in the intraoperative management of neuromuscular blockade [75], as recommended by the latest French guidelines [76] on muscle relaxants in 2020 and by new European Society of Anesthesia and Intensive Care and American Society of Anesthesiologists guidelines [75,77]. In accordance with these guidelines, the Italian intersociety consensus on perioperative anesthesia care in thoracic surgery recommends strict neuromuscular monitoring for correct administration of both NMBAs and reversal agents [78].…”
Section: Monitoring Of Neuromuscular Blockade and Adequacy Of Sedationmentioning
confidence: 99%